Appili Therapeutics Q4 Loss Narrows Amid Increase in Government Assistance

MT NewswiresJun 26 06:31 ET

Appili Therapeutics Announces Additional Bridge Loan From Bloom Burton & Co.

GlobeNewswireApr 26 19:03 ET

Appili Therapeutics Signs Definitive Agreement to Be Acquired by Aditxt, Inc.

Stockhouse Apr 2 07:30 ET

Appili Therapeutics Notes Researchers Publish Manuscript on Prevention and Emergency Response to Tularemia Outbreaks

MT NewswiresMar 12 08:28 ET

Appili Therapeutics Brief: Announcing Issuance of Patent for ATI-1701 Biodefense Vaccine Candidate to Protect Against Tularemia and Providing Update on Bridge Loan

MT NewswiresDec 15, 2023 07:27 ET

Appili Therapeutics Brief: As of September 30, 2023, Co Had Cash of $0.4 Million, Compared to $2.5 Million on March 31, 2023.

MT NewswiresNov 13, 2023 16:29 ET